55 Recruiting Trials

Clinical Trials
in Wyoming

Browse 55 recruiting clinical trials currently enrolling participants in Wyoming. Search by condition to find trials you may qualify for, at no cost.

Showing 15 of 55 recruiting trials in Wyoming

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
PHASE2 Anchorage, Alaska +4 sites · Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma
Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2 Birmingham, Alabama +4 sites · Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3 Anchorage, Alaska +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
PHASE3 Birmingham, Alabama +4 sites · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
N/A Athens, Alabama +4 sites · Lumbar Spinal Stenosis
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
PHASE2 Birmingham, Alabama +4 sites · Recurrent Meningioma, Intracranial Meningioma
Recruiting
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
PHASE3 Kingman, Arizona +4 sites · Cigarette Smoking-Related Carcinoma
Recruiting
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
N/A Anchorage, Alaska +4 sites · Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm
Recruiting
Recruiting
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
PHASE3 Birmingham, Alabama +4 sites · Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
Recruiting
Recruiting